Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Ross Stores Inc. received a series of price-target increases on Friday, as five sell-side firms lifted their estimates for the off-price retailer. Robert W. Baird led the group, moving its target to $170 from $160 while reaffirming an Outperform rating. Wells Fargo followed with a new target of $165, up from $150, and maintained an Overweight stance. Barclays raised its projection to $164 from $156, also keeping an Overweight view. JPMorgan nudged its target to $160 from $156, reiterating Overweight, and UBS set its estimate at $147, up from $144, while maintaining a Buy recommendation. The cluster of upward revisions reflects growing analyst confidence in the company’s outlook.
$ROST -Baird raises Ross Stores target to $170 from $160 Outperform -Wells Fargo raises target to $165 from $150 Overweight -Barclays raises target to $164 from $156 Overweight -JPMorgan raises target to $160 from $156 Overweight -UBS raises target to $147 from $144 Buy
$PGR -Morgan Stanley raises Progressive target to $267 from $265 = Weight - $PSKY -Guggenheim downgrades Paramount Skydance to Neutral from Buy - $QXO -Benchmark initiates QXO coverage at Buy $50 target -
$RVMD : Revolutionary Medicine; Building a Wide Moat in PDAC, Pushing Inland in NSCLC, and Forming a Beachhead in CRC; 2L+ PDAC Justifies Current Valuation; Initiating OUTPERFORM, $80 PT ( OUTPERFORM, $80.00 PT ) LIFESCI
